The Global Vagus Nerve Stimulation Market Size projected to grow at a CAGR of 10.50% from 2024 to 2031, according to a new ...

Data from the National Mental Health Survey (NMHS) indicates that India faces one of the widest treatment gaps in the world, ...

Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer –– Comprehensive ...

NewcelX Ltd. ("NewcelX"), a biotechnology company developing cell-based and small-molecule therapies for neurodegenerative ...

Report OverviewThe global botulinum toxin market is entering a phase of sustained expansion, with growth propelled by rising demand in both aesthetic and therapeutic domains. As a neurotoxin derived ...

Breakthrough Therapy Designation is intended to expedite the development and review of medicines that are intended to treat a serious or life-threatening condition and have shown preliminary clinical ...

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of ...

She shocked doctors by living to 41 with rare ‘butterfly’ disorder. She also picked up a celebrity friend along the way - IN ...

Psyence Biomedical Ltd. ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing therapies that address serious liver diseases, today announced ...

The global amyloidosis treatment market is on a trajectory of significant expansion, driven by heightened disease awareness, ...